Recent studies have suggested that CD8+ T-cell infiltration is weak in patients with early-stage lung cancer and that patients with positive CD8+ T-cell infiltration had a higher percentage of subclonal mutations (23, 46). This evidence concerns the gene CD8A and lung cancer.